Genome Sequencing Services Facility by InterpretOmics to start in Banglore
Banglore :Genomic data science company InterpretOmics on Monday announced opening a next generation facility here to offer genome sequencing services to research and development institutes, pharma units and biotech firms.Set up at a cost of Rs.3.5 crore, the hit-tech facility will also be a biomarker discovery, drug target discovery and trial stratification for biotech, pharma and contract research organisations.
"We will provide genomic selection of specific trains in crop development for bio-agriculture firms," InterpretOmics, a research company dedicated to the discovery of novel and innovative approaches to the treatment of complex diseases, said in a statement here.
"The newly inaugurated centre will cater to our growing customer base in next generation sequencing and analysis. The facility also houses a bio-bank," said its co-founder and CEO Prahalad Achutharao.
"The focus is on research, development and delivering model (RDD). Our USP is carrying out R&D along with the delivery. InterpretOmics now has 35 professionals and plans to achieve a head count of 40 by the end of July," he added.
InterpretOmics also provides on-premise and SaaS enterprise-grade software platform for research organisations, pharmaceuticals, biotechnology firms and hospitals to analyse genetic information and identify biomarkers critical to the development of targeted drugs and therapies, the company said in the statement.
"We will provide genomic selection of specific trains in crop development for bio-agriculture firms," InterpretOmics, a research company dedicated to the discovery of novel and innovative approaches to the treatment of complex diseases, said in a statement here.
"The newly inaugurated centre will cater to our growing customer base in next generation sequencing and analysis. The facility also houses a bio-bank," said its co-founder and CEO Prahalad Achutharao.
"The focus is on research, development and delivering model (RDD). Our USP is carrying out R&D along with the delivery. InterpretOmics now has 35 professionals and plans to achieve a head count of 40 by the end of July," he added.
InterpretOmics also provides on-premise and SaaS enterprise-grade software platform for research organisations, pharmaceuticals, biotechnology firms and hospitals to analyse genetic information and identify biomarkers critical to the development of targeted drugs and therapies, the company said in the statement.
The process of Genome sequencing involves the sequencing of the entire genome ( the genetic content of an organism).
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.